Deutsche Bank’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.12M | Buy |
225,169
+148,392
| +193% | +$4.69M | ﹤0.01% | 1096 |
|
|
2025
Q1 | $2.55M | Sell |
76,777
-9,172
| -11% | -$304K | ﹤0.01% | 1577 |
|
|
2024
Q4 | $2.96M | Buy |
85,949
+18,939
| +28% | +$652K | ﹤0.01% | 1597 |
|
|
2024
Q3 | $2.68M | Buy |
67,010
+21,728
| +48% | +$869K | ﹤0.01% | 1565 |
|
|
2024
Q2 | $1.37M | Sell |
45,282
-4,353
| -9% | -$131K | ﹤0.01% | 1815 |
|
|
2024
Q1 | $1.67M | Sell |
49,635
-32,252
| -39% | -$1.08M | ﹤0.01% | 1733 |
|
|
2023
Q4 | $2.64M | Buy |
81,887
+65,420
| +397% | +$2.11M | ﹤0.01% | 1515 |
|
|
2023
Q3 | $540K | Sell |
16,467
-58,008
| -78% | -$1.9M | ﹤0.01% | 2094 |
|
|
2023
Q2 | $2.62M | Buy |
74,475
+26,313
| +55% | +$926K | ﹤0.01% | 1497 |
|
|
2023
Q1 | $1.57M | Sell |
48,162
-75,266
| -61% | -$2.46M | ﹤0.01% | 1821 |
|
|
2022
Q4 | $6.8M | Buy |
123,428
+79,862
| +183% | +$4.4M | ﹤0.01% | 1108 |
|
|
2022
Q3 | $1.93M | Buy |
43,566
+30,352
| +230% | +$1.34M | ﹤0.01% | 1642 |
|
|
2022
Q2 | $645K | Sell |
13,214
-54
| -0.4% | -$2.64K | ﹤0.01% | 2431 |
|
|
2022
Q1 | $645K | Sell |
13,268
-1,243
| -9% | -$60.4K | ﹤0.01% | 2586 |
|
|
2021
Q4 | $618K | Sell |
14,511
-76,865
| -84% | -$3.27M | ﹤0.01% | 2690 |
|
|
2021
Q3 | $3.5M | Buy |
91,376
+8,255
| +10% | +$316K | ﹤0.01% | 1710 |
|
|
2021
Q2 | $2.35M | Buy |
83,121
+79,142
| +1,989% | +$2.23M | ﹤0.01% | 2074 |
|
|
2021
Q1 | $131K | Sell |
3,979
-378
| -9% | -$12.4K | ﹤0.01% | 3785 |
|
|
2020
Q4 | $158K | Buy |
+4,357
| New | +$158K | ﹤0.01% | 3532 |
|